Metachromatic Leukodystrophy

MLD is a rare, genetic, degenerative, neurometabolic disorder that affects 1 in 40,000 people worldwide.

Pompe Disease

There are up to 70 different mutations in the GAA gene that cause the symptoms of Pompe disease.

CRISPR Gene Editing to Treat Rare Diseases

A new wave of treatments based on gene editing technology are expected to be made available over the next few years. 

Distal Muscular Dystrophy

Distal muscular dystrophy is a general term for a group of rare progressive genetic disorders.

The Evolving Market Access (MA) Landscape in the GCC Region

What are the changes pharmaceutical companies need to be aware of and how to manage them?

The case for Rare Disease Clinical Trials in the Middle East

The objective of this paper is to address clinical trials inclusion in the Middle East.
1 2 3 4